|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Abstract |
|---|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
A critical feature of sepsis-induced acute lung injury is the release of cytokines from endotoxin (LPS)- stimulated alveolar macrophages (AM). LPS is also known to activate various members of the mitogen- activated protein kinase (MAPK) family in other types of cells. In this study, we evaluated whether multiple members of the MAPK family regulate cytokine gene expression in LPS-stimulated AM. We found that LPS activates both the extracellular signal-regulated kinase (Erk) and p38 kinases, and that this activation is augmented when the cells are cultured in serum. Inhibition of either the Erk (with PD98059) or p38 (with SB203580) kinase pathway resulted in only a partial reduction in cytokine (interleukin-6 and tumor necrosis factor) messenger RNA accumulation and cytokine release, whereas inhibition of both pathways simultaneously resulted in a decrease in cytokine gene expression to near-control levels. Nuclear run-on assays showed that the effect of these MAPK pathways on LPS-induced expression of the cytokine genes was attributable, at least in part, to regulation of gene transcription. These findings suggest that activation of both the Erk and p38 kinase pathways is necessary for optimal cytokine gene expression in LPS-stimulated human AM, and that the MAPK pathways play a critical role in the inflammatory response that occurs in sepsis-induced acute lung injury.
| |
Introduction |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
One form of lung injury that often results from sepsis is the adult respiratory distress syndrome (ARDS) (1). Although many factors contribute to the inflammatory process that occurs in ARDS, one of the early and ongoing factors is the release of cytokines from alveolar macrophages (AM). Endotoxin (LPS), which is released during sepsis, is a major stimulus for the release of cytokines from AM, and a prolonged release of cytokines by AM has been associated with a more adverse outcome in patients with this disease (2).
One closely related group of kinases known to be activated by LPS in other types of cells are the mitogen-activated protein kinases (MAPKs) (5). Three important
groups of kinases compose the MAPK family, including
the p42/44 (also known as extracellular signal-regulated
kinase [Erk]) kinases, the c-Jun N-terminal kinases (JNK),
and the p38 kinases. Prior studies in monocytes (5, 6) have
shown that the p38 MAPK pathway is critical for LPS- induced cytokine release. In these studies, specific inhibition of the p38 kinase pathway by SB203580 resulted in reduced cytokine release secondary to a defect in translation
(5). No other studies, using any type of cells, have evaluated whether other MAPK pathways are required for optimal LPS-induced expression of cytokine genes. The only
potentially relevant study is by Reimann and colleagues
(15), who used BAC-1.2F5 macrophages and showed that
expression of v-raf resulted in activation of the Erk kinases and the release of small amounts of interleukin (IL)-
1
and tumor necrosis factor (TNF)-
. Exposure of these
v-raf-infected cells to LPS resulted in expression of
greater amounts of cytokine messenger RNAs (mRNAs).
BAC-1.2F5 macrophages infected with v-raf, however, exhibit a suppression of LPS-induced Erk kinase activation
(15). Thus, it is not clear from this study whether the effect
of LPS was mediated through the Erk kinase pathway or
some other pathway.
Other studies have linked immunoglobulin (Ig) G-mediated or IgE-mediated activation of Erk kinases in leukocytes and murine macrophages or mast cells, respectively,
to the expression of the TNF gene (16). These effects
of IgG or IgE on TNF gene expression could be inhibited
by PD98059, a selective inhibitor of the MEK
Erk kinase
pathway. In the studies that used IgG as a stimulus, activation of the p38 kinase pathway was not linked to expression of the TNF gene (16, 17); whereas in the study that
used IgE as a stimulus, the p38 kinase negatively regulated
the Erk kinases and TNF gene expression (18). To our
knowledge, no studies have linked expression of the Erk
kinase pathway to cytokine gene expression in cells stimulated with LPS. Furthermore, no studies have shown that
both the Erk and p38 kinase pathways contribute to optimal cytokine gene expression with any type of stimulus.
We hypothesized that activation of both the Erk and
p38 kinase pathways may be necessary for optimal LPS-
induced cytokine gene expression in AM. For these studies we used human AM because they are relevant cells
that release cytokines in the lungs of patients with sepsis-induced acute lung injury. We found that LPS activates
both Erk and p38 kinases in AM, and that this activation is
enhanced by the presence of serum. LPS-induced Erk kinase activity could be reduced to control levels with PD98059, a specific inhibitor of the MEK Erk kinase pathway, and p38 kinase activity could be reduced to control
levels with SB203580, a specific inhibitor of the p38 kinase
pathway. LPS increased amounts of IL-6 and TNF mRNAs
and proteins in AM. Although inhibition of either the Erk or p38 kinases resulted in a small reduction, inhibition of
both pathways reduced LPS-induced cytokine gene expression to near-control levels. The effects of PD98059 and
SB203580 on cytokine gene expression were due, at least
in part, to inhibition of gene transcription.
| |
Materials and Methods |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
Isolation of AM
The use of normal volunteers to obtain AM by bronchoalveolar lavage (BAL) and human blood monocytes by phlebotomy was approved by the Human Subjects Review Board of the University of Iowa College of Medicine (Iowa City, IA). AM and monocytes were obtained from normal volunteers who met the following criteria: (1) age between 18 and 45 yr; (2) no history of cardiopulmonary disease or other chronic disease; (3) no prescription or nonprescription medication except oral contraceptives; (4) no recent or current evidence of infection; and (5) lifetime nonsmoker. The volunteers underwent phlebotomy and/or fiberoptic bronchoscopy with BAL in subsegments of the right upper lobe, right middle lobe, and lingula after receiving intramuscular atropine, 0.6 mg, and local anesthesia. Each subsegment of the lung was lavaged with five 20-ml aliquots of normal saline, and the first aliquot in each was discarded. The percentage of AM was determined by Wright-Giemsa stain and varied from 90 to 98%.
Expression of MAPK
AM were cultured at 37°C for 15 to 30 min in Roswell
Park Memorial Institute (RPMI)-1640 medium with 5%
fetal calf serum (FCS), and they were stimulated with Escherichia coli serotype 026:B6 LPS (Sigma, St. Louis, MO)
at a dose of 1 µg/ml. The MEK inhibitor PD98059 (New
England Biolabs, Beverly, MA), at 10 µM, and the p38 inhibitor SB203580 (Calbiochem, La Jolla, CA), at 1 µM,
were added 1 h before stimulation with LPS. These concentrations of PD98059 and SB203580 are approximately
twice the concentration that is necessary to inhibit their respective kinases (IC50), according to the product information and relevant literature (6, 18). In our AM and monocytes, these concentrations represented approximately twice
the IC50 as well. These concentrations of inhibitors were
not toxic to the cells, as evaluated by trypan blue stain. Experiments with short time courses, such as kinase assays,
had cell viabilities greater than 90% in all groups. Experiments with long time courses, such as enzyme-linked immunosorbent assays (ELISAs), had cell viabilities ranging
from 60 to 80% in all groups. The cells were harvested,
resuspended in a lysis buffer (1% NP-40, 0.15 M NaCl,
0.05 M Tris [pH 7.4], 100 µg/ml phenylmethylsulfonyl fluoride, 50 µg/ml aprotinin, 10 µg/ml leupeptin, 50 µg/ml pepstatin, 0.4 M Na3VO4, 10 mM NaF, and 10 mM sodium
pyrophosphate), sonicated, and placed on ice for 20 min.
After centrifuging at 14,000 rpm at 4°C for 10 min to remove cellular debris, the lysates were stored at 
70°C.
Erk2 and p38 were immunoprecipitated from the lysates
(600 µg) overnight at 4°C with their respective antibodies (Santa Cruz Biotechnology, Santa Cruz, CA) bound to
Gammabind with sepharose (Pharmacia Biotech, Uppsala,
Sweden). The sepharose pellet was placed in a kinase buffer
(20 mM MgCl2, 25 mM N-2-hydroxyethylpiperazine-N'-ethane sulfonic acid, 20 mM -glycerophosphate, 20 mM
p-nitrophenylphosphate, 0.1 mM NaVO4, and 2 mM dithiothreitol) with [
-32P]adenosine triphosphate (ATP) (5 µCi/
sample; New England Nuclear/DuPont, Boston, MA),
ATP, and myelin basic protein (MBP; Sigma). Kinase activity was assayed by phosphorylation of MBP for both Erk2
and p38. After 15 min, the kinase reaction was stopped with
the addition of ethylenediaminetetraacetic acid (EDTA)-
containing Laemmli sample buffer, and the samples were
heated to 95°C for 5 min to separate the protein from the
sepharose. The samples were separated on a 10% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) discontinuous gel at 45 mA. The gels were subsequently vacuum-dried and exposed to autoradiographic
film at room temperature. Western blot analysis was performed simultaneously, with equal aliquots taken from
each sample after immunoprecipitation to ensure equal
loading of the kinases. The samples for the kinase assay and
the Western analysis were run on separate SDS-PAGE discontinuous gels.
Expression of Cytokine mRNA
Whole-cell RNA was isolated using RNA Stat-60 according to the manufacturer's instructions (Tel-test "B";
Friendswood, TX). Cells were lysed in RNA Stat-60 solution, containing phenol and guanidinium thiocyanate. The
mixture was then shaken vigorously, allowed to sit for 2 to
3 min, and then centrifuged at 12,000 rpm for 15 min at
4°C. The RNA was removed from the upper aqueous layer, precipitated with isopropanol for 30 min, centrifuged at 12,000 rpm for 10 min at 4°C, and washed with
75% ethanol. The isolated RNA was fractionated in a
1.5% denaturing agarose gel containing 2.2 M formaldehyde. An RNA ladder (0.24 to 9.5 kb; Life Technologies,
Gaithersburg, MD) was included as a molecular-size standard. RNA loading was confirmed by equivalent ethidium
bromide staining in each lane. The RNAs were transferred
to GeneScreen Plus paper (New England Nuclear/DuPont) as suggested by the manufacturer. IL-6 and TNF
complementary DNA (cDNA) probes (generated by polymerase chain reaction [PCR]; Clontech, Palo Alto, CA)
were labeled with [-32P]cytidine triphosphate (CTP) (New
England Nuclear/DuPont) by random primer method. Blots
were prehybridized for 3 h at 42°C (10 ml formamide, 5 mM
NaCl, 4 ml 50% dextran, 10% SDS, 1 M Tris [pH 7.0], and
0.4 ml 50× Denhardt's solution) and then hybridized with
the labeled probe overnight at 42°C. The filters were washed twice with 1× saline sodium citrate (SSC) at 25°C, twice with 1× SSC plus 1% SDS at 65°C, and then once with 0.1×
SSC at 25°C. The filters were exposed to autoradiographic
film at 70°C.
Nuclear Run-On Assay
For these studies, AM were cultured in RPMI medium
with 5% FCS for 3 h at 37°C in the presence or absence of
LPS and in the presence or absence of PD98059 or SB203580. The cells were harvested and washed with ice-cold
phosphate-buffered saline. The cells were lysed in a lysis
buffer (10 mM Tris [pH 7.4], 10 mM NaCl, 3 mM MgCl2,
and 0.5% NP-40), and left on ice for 5 min. After centrifuging at 1,500 rpm for 5 min at 4°C, the nuclear pellet was
resuspended in a glycerol storage buffer and stored at
70°C. To assay nuclear transcription, the nuclear pellets
were thawed and placed in a reaction buffer (10 mM Tris
[pH 8.0], 5 mM MgCl2, 0.3 M KCl) with 1 mM of nucleotides (ATP, CTP, and guanosine triphosphate), and 10 µl
of [-32P]uridine triphosphate (400 µCi/sample; New England Nuclear/DuPont), and each sample was placed in an
orbital shaker for 30 min at 30°C. The reaction was stopped
with the addition of 1 mg/ml of ribonuclease (RNase)-free
DNase I (Promega, Madison, WI) and 20 mg/ml of proteinase K (Life Technologies). RNA was extracted with phenol/chloroform/isoamyl alcohol (25:24:1). The RNA solution was then placed in 10% trichloroacetate/60 mM sodium pyrophosphate with 10 µl of 10 mg/ml transfer RNA
and left on ice for 30 min. The precipitate was filtered onto
0.45-µm filters, and the 32P-labeled RNA was eluted. The
RNA was precipitated for 30 min on dry ice and centrifuged for 30 min at 9,000 rpm at 4°C. The pellet was resuspended in 1 ml of TES solution (10 mM N-tris[hydroxymethyl]methyl-2-aminoethanesulfonic acid [pH 7.4], 10 mM EDTA, and 0.2% SDS). The samples were counted and equalized by counts per minute of 32P-labeled RNA/
ml. The equalized samples were then hybridized at 65°C
for 36 h to IL-6 cDNA (generated by PCR; Clontech) that was previously bound to nitrocellulose. The nitrocellulose
filters were washed six times in 1× saline sodium phosphate EDTA (SSPE) with 1% SDS at 65°C, once in 0.1×
SSPE with 1% SDS at 65°C, once in 2× SSPE with RNase
A 1.25 µg/ml at 37°C, and three times in 2× SSPE at room
temperature. The filters were allowed to dry at room temperature and subsequently exposed to autoradiographic film at 70°C.
Expression of Cytokines
For these studies, AM were cultured in RPMI medium with 5% FCS for 24 h in the presence or absence of LPS and with and without inhibitors, as described above. The amounts of IL-6 and TNF in the supernatant of the cells were measured by ELISA (R&D Systems, Minneapolis, MN).
Statistical Analysis
All of the cytokine measurements are shown as means with standard error. Statistical comparisons were performed using an unpaired, one tailed t test with a probability value of P < 0.05 considered to be significant.
| |
Results |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
MAPK Activation by LPS in Human AM
To determine the time at which maximal kinase activity is expressed, we stimulated AM with LPS for 5, 15, 30, and 60 min before evaluating kinase activity. For the Erk2 kinase, the greatest activity was at 15 min, but there was detectable kinase activity as early as 5 min and as late as 60 min after LPS stimulation (Figure 1A). For the p38 kinase, activity was maximal at 30 min and the kinase remained active at 60 min (Figure 1B). AM cultured in serum-free conditions with LPS expressed increased activity of both Erk2 and p38 kinases, but cells cultured in RPMI medium with 5% serum and LPS had much greater activation of these kinases (Figure 2). These are the first studies to show that LPS activates both Erk and p38 kinases in human AM. The studies further show that serum augments this effect of LPS.
|
|
Selective Inhibition of Erk and p38 Kinases in Human AM
To evaluate the role of the Erk and p38 kinase pathways in regulating the release of cytokines from LPS-stimulated AM, it was necessary to inhibit each pathway selectively. To determine whether the inhibitors were specific for each pathway, we performed kinase assays and Western blot analysis of both the Erk2 and p38 kinases. The LPS-induced Erk2 kinase activity could be significantly reduced by PD98059, a specific inhibitor of the Erk kinase pathway (Figure 3A), and the p38 kinase activity could be significantly reduced by SB203580, a specific inhibitor of this pathway (Figure 3B). PD98059 had no detectable effect on activation of the p38 kinase, and SB203580 had no detectable effect on activation of the Erk kinase. These studies show that the inhibitors are effective and specific, and the results are consistent with prior studies that also showed the specificity of these inhibitors (5, 17, 18, 20, 24, 25).
|
Both Erk and p38 Kinase Pathways Are Necessary for Maximal LPS-Induced Cytokine Release in Human AM
To determine whether both the Erk and p38 kinase pathways regulate cytokine release, we measured the release of IL-6 and TNF from LPS-stimulated AM. As expected, LPS markedly increased the release of both cytokines. Inhibition of either the Erk or p38 kinase pathway only partially reduced cytokine release. Increasing the amounts of each of the inhibitors had no additional effect on cytokine release (data not shown). In contrast, simultaneous inhibition of both pathways reduced cytokine release to near-control levels (Figure 4). These studies strongly suggest that LPS-stimulated AM require activation of both the Erk and the p38 kinase pathways for optimal cytokine release.
|
LPS-Induced Activation of Both the Erk and the p38 Kinase Pathways Regulates Accumulation of Cytokine mRNAs in Human AM
To determine the effect of the Erk and p38 kinase pathways on accumulation of cytokine mRNAs, we performed Northern blot analysis to detect IL-6 and TNF mRNAs in LPS-stimulated AM. As expected, LPS increased the amounts of IL-6 and TNF mRNAs. Selective inhibition of either the Erk or p38 kinase pathways with PD98059 or SB203580, respectively, partially reduced the accumulation of each of the cytokine mRNAs. The combination of the two inhibitors resulted in a greater reduction in the amounts of the cytokine mRNAs, compared with either inhibitor alone (Figure 5). The observation that inhibition of the p38 kinase pathway reduces cytokine mRNA accumulation contrasts with the data of Lee and associates in monocytes (5). Therefore, we performed similar studies in monocytes. The results of these studies were similar to our studies in AM (Figure 6). These observations suggest that the Erk and p38 kinase pathways regulate either transcription or stability of the cytokine mRNAs.
|
|
LPS-Induced Activation of Both the Erk and the p38 Kinase Pathways Is Necessary for Cytokine Gene Transcription in Human AM
To determine whether PD98059 or SB203580 altered transcription of the cytokine genes, we performed nuclear run-on assays to evaluate IL-6 transcription in LPS-stimulated AM. LPS increased levels of IL-6 gene transcription in AM, and inhibition of the Erk kinase pathway with PD98059 or the p38 kinase pathway with SB203580 markedly reduced cytokine gene transcription (Figure 7). These studies suggest that both the Erk and p38 kinase pathways regulate cytokine gene expression, at least in part, at the level of transcription in AM exposed to LPS.
|
| |
Discussion |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
One of the major causes of ARDS is sepsis. During sepsis there are increased amounts of LPS in the lungs of affected patients, and LPS is a major stimulus for the release of cytokines during the course of the illness. In these studies, we found that both the Erk kinase and p38 kinase pathways are activated in human AM exposed to LPS. Both of these MAPK pathways are activated by LPS alone but this effect is enhanced when AM are cultured in serum, which is known to enhance the effects of LPS. Most importantly, we observed that activation of both the Erk and p38 kinase pathways was necessary for optimal accumulation of IL-6 and TNF mRNAs and cytokine release from LPS-stimulated AM. Inhibition of either of these pathways only partially reduced cytokine gene expression, but simultaneous inhibition of both pathways resulted in a marked reduction in expression of these genes. Nuclear run-on assays showed that one mechanism by which the Erk and p38 kinase pathways regulate accumulation of the cytokine mRNAs is by an effect on transcription. To our knowledge, these are the first studies to show that several MAPK pathways interact positively to regulate expression of cytokine genes. They are also the first studies to show clearly that the Erk kinase pathway regulates cytokine gene expression in response to LPS.
Prior studies by Lee and coworkers (5, 6), using monocytes and LPS to stimulate the cells, showed that inhibition
of the p38 kinase pathway with SB203580 resulted in an inhibition of cytokine release. The Erk kinase pathway was
not evaluated in these studies. Other stimuli, such as osmotic stress and IL-1, also activate p38 kinases and cytokine gene expression (21). Both osmotic stress and IL-1 increase amounts of cytokine mRNAs in monocytes and
THP-1 cells. Inhibition of the p38 kinases with SB203580
results in reduced cytokine release but not a decrease in
cytokine mRNA accumulation. Thus, it appears from these
studies that SB203580 inhibits the translation of cytokine
mRNAs in cells stimulated by a variety of stimuli. The mechanism(s) by which the p38 kinase might regulate translation
of cytokine mRNAs is, at present, unknown. It has been
postulated that phosphorylation at an AU-rich (AUUUA
repeat in the 3' end of mRNA) site in cytokine mRNAs is
important in regulating translation (5). In our studies, we
consistently observed a reduction in LPS-induced accumulation of cytokine mRNAs when we inhibited the p38 kinase pathway. This was seen both in AM and in monocytes. By itself, however, inhibition of cytokine mRNA
accumulation by SB203580 was only partial. This may explain the differences between our study and prior studies. Our studies clearly show that inhibition of p38 kinases
with SB203580 reduces cytokine gene transcription. In this
regard, it is known that the p38 kinases also phosphorylate
various transcription factors, such as activating transcription factor-2 (ATF2), at sites that increase their transcriptional activity (8, 26, 28). ATF2 is thought to positively regulate, with subunits of nuclear factor (NF)-
B, expression
of the promoters of several cytokine genes (29). Another
study has also shown that the p38 kinase activates a member of the CAAT/enhancer binding protein (C/EBP) family
(30). These observations suggest mechanisms by which the
p38 kinases might regulate transcription.
The two important findings in our study are that the Erk kinase pathway is also necessary for optimal LPS- induced cytokine gene expression in human AM, and that there is a positive interaction between the Erk and p38 kinases in regulating LPS-induced cytokine gene expression. Studies have shown that LPS can activate Erk kinases (7, 9). However, to our knowledge, no study has shown that the Erk kinases are involved in LPS-induced cytokine gene expression. The only study that has linked Erk kinases to LPS-induced cytokine gene expression was in BAC-1.2F5 macrophages (15). These cells, which were infected with v-raf, released small amounts of cytokines at baseline, and the amount of cytokine mRNAs increased when the cells were exposed to LPS. BAC-1.2F5 macrophages, however, exhibit suppression of LPS-induced Erk kinase activation when infected with v-raf. Thus, it is not clear whether the effect of LPS was mediated through the Erk kinases or through some other pathway. Erk kinase activation by IgG or IgE in neutrophils and murine macrophages or mast cells has previously been linked to cytokine (TNF) gene expression (16). These studies, however, either did not evaluate Erk kinase interactions with p38 kinases or showed a negative regulation of cytokine gene expression by the p38 kinase (18). Our studies strongly suggest that both Erk and p38 kinases positively interact to regulate cytokine gene expression in human AM.
The mechanism(s) by which Erk kinases regulate LPS-induced cytokine gene expression is unknown. Our study
shows that this regulation is, at least in part, at the level of
transcription. Various studies have suggested that NF-B
activity can be regulated via phosphorylation (31). It will
be of interest in future studies to determine whether LPS
induces phosphorylation of subunits of NF-B, and whether
this is regulated by either the Erk or the p38 kinases. Other
transcription factors, such as activator protein-1 (AP-1)
and C/EBP (also known as NF-IL-6) can also mediate activation of the IL-6 and TNF genes (32). Many studies
have shown that the Erk kinases are necessary for AP-1
activation (32) in several types of cells. Erk kinase is
thought to increase AP-1 transcriptional activity by induction of c-fos, and it phosphorylates c-Jun in N-terminal sites
(32). One study has shown that Erk kinases regulate the
phosphorylation of NF-IL-6 in vitro (41). The Erk kinases
are also known to phosphorylate additional transcription factors (42), including Elk-1, c-Myc, and cyclic adenosine monophosphate response element binding protein. The
role of these transcription factors in mediating cytokine
gene expression is less defined.
The JNK kinases are also activated by LPS (10, 11, 13), and they may play a role in regulating cytokine gene expression. This likely is the case because it is known that these kinases regulate the activity of various transcription factors (32, 35, 46). We did not pursue the role of the JNK kinases in this study because there are no specific inhibitors for these kinases that can be used in normal cells. Simultaneous inhibition of both the Erk and p38 kinase pathways reduces cytokine gene expression to near-control levels, so our studies suggest that activation of the JNK kinase pathway by itself is not sufficient for expression of the IL-6 and TNF genes.
In summary, human AM require both the Erk and p38 kinase pathways for optimal LPS-induced IL-6 and TNF gene expression. Both the Erk and p38 kinases regulate the expression of cytokine genes, at least in part, at the level of transcription. Thus, these studies suggest that there is a positive interaction between these kinases in LPS-stimulated AM, unlike the interaction seen in other cells. These studies also suggest that the MAPK pathways play an important role in the inflammatory response that occurs in sepsis- induced acute lung injury.
| |
Footnotes |
|---|
Address correspondence to: Aaron Brent Carter, M.D., Div. of Pulmonary and Critical Care Medicine, C33 GH, University of Iowa Hospital and Clinics, 200 Hawkins Dr., Iowa City, IA 52242. E-mail: aaron-carter{at}uiowa.edu
(Received in original form May 15, 1998 and in revised form September 2, 1998).
Abbreviations: alveolar macrophages, AM; activator protein-1, AP-1; adult respiratory distress syndrome, ARDS; adenosine triphosphate, ATP; extracellular signal-regulated kinase, Erk; fetal calf serum, FCS; immunoglobulin, Ig; interleukin, IL; c-Jun N-terminal kinases, JNK; endotoxin, LPS; mitogen-activated protein kinase, MAPK; MAPK kinase, MEK; messenger RNA, mRNA; nuclear factor, NF; sodium dodecyl sulfate-polyacrylamide gel electrophoresis, SDS-PAGE; saline sodium citrate, SSC; saline sodium phosphate ethylenediaminetetraacetic acid, SSPE; tumor necrosis factor, TNF.Acknowledgments: These studies were supported by National Institutes of Health grants HL37121 (G.W.H.), AI35018 (G.W.H), HL03860 (A.B.C.), and by a VA Merit Review Grant.
| |
References |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
1. Hudson, L. D., J. A. Milberg, D. Anardi, and R. J. Maunder. 1995. Clinical risks for the development of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 151: 293-301 [Abstract].
2. Pittet, J. F., R. C. Mackersie, T. R. Martin, and M. A. Matthay. 1997. Biological markers of acute lung injury: prognostic and pathogenetic significance. Am. J. Respir. Crit. Care Med. 155: 1187-1205 [Medline].
3.
Meduri, G. U.,
S. Healey,
G. Kohler,
F. Stentz,
E. Tollet,
R. Umberger, and
K. Leeper.
1995.
Persistent elevation of inflammatory cytokines predicts a
poor outcome in ARDS: plasma IL-1 and IL-6 levels are consistent and
efficient predictors of outcome over time.
Chest
107:
1062-1173
4.
Meduri, G. U.,
G. Kohler,
S. Healey,
E. Tolley,
F. Stentz, and
A. Postlethwaite.
1995.
Inflammatory cytokines in the BAL of patients with ARDS:
persistent elevation over time predicts poor outcome.
Chest
108:
1303-1314
5. Lee, J. C., J. T. Laydon, P. C. McDonnell, T. F. Gallagher, S. Kumar, D. Green, D. McNulty, J. E. Strickler, M. M. McLaughlin, I. R. Siemens, S. M. Fisher, G. P. Livi, J. R. White, J. L. Adams, and P. R. Young. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372: 739-746 [Medline].
6. Lee, J. C., and P. R. Young. 1996. Role of CSBP/p38/RK stress response kinase in LPS and cytokine signaling mechanisms. J. Leukoc. Biol. 59: 152-157 [Abstract].
7. Liu, M. K., P. Herrera-Velit, R. W. Brownsey, and N. E. Reiner. 1994. CD 14-dependent activation of protein kinase C and mitogen-activated protein kinases (p42 and p44) in human monocytes treated with bacterial lipopolysaccharide. J. Immunol. 153: 2642-2652 [Abstract].
8. Nick, J. A., N. J. Avdi, P. Gerwins, G. L. Johnson, and G. S. Worthen. 1996. Activation of a p38 mitogen-activated protein kinase in human neutrophils by lipopolysaccharide. J. Immunol. 156: 4867-4875 [Abstract].
9. Sanghera, J. S., S. L. Weinstein, M. Aluwalia, J. Girn, and S. L. Pelech. 1996. Activation of multiple proline-directed kinases by bacterial lipopolysaccharide in murine macrophages. J. Immunol. 156: 4457-4465 [Abstract].
10.
Han, J.,
J.-D. Lee,
L. Bibbs, and
R. J. Ulevitch.
1994.
A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells.
Science
265:
808-811
11.
Hambleton, J.,
S. L. Weinstein,
L. Lem, and
A. L. DeFranco.
1996.
Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated
macrophages.
Proc. Natl. Acad. Sci. USA
93:
2774-2778
12. Guthridge, C. J., D. Eidlen, W. P. Arend, A. Gutierrez-Hartmann, and M. F. J. Smith. 1997. Lipopolysaccharide and Raf-1 kinase regulate secretory interleukin-1 receptor antagonist gene expression by mutually antagonistic mechanisms. Mol. Cell. Biol. 17: 1118-1128 [Abstract].
13.
Weinstein, S. L.,
J. S. Sanghera,
K. Lemke,
A. L. DeFranco, and
S. L. Pelech.
1992.
Bacterial lipopolysaccharide induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in macrophages.
J. Biol. Chem.
267:
14955-14962
14. Joto, N., T. Akimoto, K. Someya, and A. Tohgo. 1995. Production of tumor necrosis factor induced by synthetic low-toxicity lipid A analog, DT-5461a, is mediated by LPS receptor sites and tyrosine kinase-MAP kinase signaling pathway in murine macrophages. Cell Immunol. 160: 1-7 [Medline].
15.
Reimann, T.,
D. Buscher,
R. A. Hipskind,
S. Krautwald,
M.-L. Lohmann-Matthes, and
M. Baccarini.
1994.
Lipopolysaccharide induces activation of
the Raf-1/MAP kinase pathway: a putative role for Raf-1 in the induction
of IL-1 and the TNF- genes.
J. Immunol.
153:
5740-5749
[Abstract].
16.
Trotta, R.,
P. Kanakaraj, and
B. Perussia.
1996.
FcR-dependent mitogen-activated protein kinase activation in leukocytes: a common signal transduction event necessary for expression of TNF- and early activation
genes.
J. Exp. Med.
184:
1027-1035
17.
Rose, D. M.,
B. W. Winston,
E. D. Chan,
D. W. H. Riches,
P. Gerwins,
G. L. Johnson, and
P. M. Henson.
1997.
Fc receptor cross-linking activates p42, p38, and JNK/SAPK mitogen-activated protein kinases in murine macrophages: role for p42MAPK in Fc receptor-stimulated TNF- synthesis.
J. Immunol.
158:
3433-3438
[Abstract].
18.
Zhang, C.,
R. A. Baumgartner,
K. Yamada, and
M. A. Beaven.
1997.
Mitogen-activated protein (MAP) kinase regulates production of tumor necrosis factor- and release of arachidonic acid in mast cells: indications of
communication between p38 and p42 MAP kinases.
J. Biol. Chem.
272:
13397-13402
19.
Dudley, D. T.,
L. Pang,
S. J. Decker,
A. J. Bridges, and
A. R. Saltiel.
1995.
A synthetic inhibitor of the mitogen-activated protein kinase cascade.
Proc. Natl. Acad. Sci. USA
92:
7686-7689
20.
Alessi, D. R.,
A. Cuenda,
P. Cohen,
D. T. Dudley, and
A. R. Saltiel.
1995.
PD 098059 is a specific inhibitor of mitogen-activated protein kinase kinase in vitro and in vivo.
J. Biol. Chem.
270:
27489-27494
21.
Shapiro, L., and
C. A. Dinarello.
1995.
Osmotic regulation of cytokine synthesis in vitro.
Proc. Natl. Acad. Sci. USA
92:
12230-12234
22.
Saklatvala, J.,
L. Rawlinson,
R. J. Waller,
S. Sarsfield,
J. C. Lee,
L. F. Morton,
M. J. Barnes, and
R. W. Farndale.
1996.
Role of p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue.
J. Biol. Chem.
271:
6586-6589
23.
Kumar, S.,
M. J. Orsini,
J. C. Lee,
P. C. McDonnell,
C. Debouck, and
P. R. Young.
1996.
Activation of the HIV-1 long terminal repeat by cytokines
and environmental stress requires an active CSBP/p38 MAP kinase.
J.
Biol. Chem.
271:
30864-30869
24. Cuenda, A., J. Rouse, Y. N. Doza, R. Meier, P. Cohen, T. F. Gallagher, P. R. Yound, and J. C. Lee. 1995. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364: 229-233 [Medline].
25.
Pang, L.,
T. Sawanda,
P. Cohen,
D. T. Dudley, and
A. R. Saltiel.
1995.
Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor.
J. Biol. Chem.
270:
13585-13588
26. Cuenda, A., P. Cohen, V. Buee-Scherrer, and M. Goedert. 1997. Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6): comparison of the specificities of SAPK3 and SAPK2 (RK/p38). EMBO J. 16: 295-305 [Medline].
27.
Derijard, B.,
J. Raingeaud,
T. Barrett,
I. Wu,
J. Han,
R. J. Ulevitch, and
R. J. Davis.
1995.
Independent human MAP kinase signal transduction
pathways defined by MEK and MKK isoforms.
Science
267:
682-685
28.
Raingeaud, J.,
S. Gupta,
J. S. Rogers,
M. Dickens,
J. Han,
R. J. Ulevitch, and
R. J. Davis.
1995.
Pro-inflammatory cytokines and environmental
stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine.
J. Biol. Chem.
270:
7420-7426
29. Stein, B., A. S. Baldwin Jr., D. W. Ballard, W. C. Greene, P. Angel, and P. Herrlich. 1993. Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J. 12: 3879-3891 [Medline].
30. Wang, X., and D. Ron. 1996. Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP kinase. Science 272: 1347-1349 [Abstract].
31.
Meyer, C. F.,
X. Wang,
C. Chang,
D. Templeton, and
T.-H. Tan.
1996.
Interaction between c-Rel and the mitogen-activated protein kinase kinase
kinase 1 signaling cascade in mediating B enhancer activation.
J. Biol.
Chem.
271:
8971-8976
32.
Minden, A.,
A. Lin,
T. Smeal,
D. Derijard,
M. Cobb,
R. Davis, and
M. Karin.
1994.
c-Jun N-terminal phosphorylation correlates with activation
of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases.
Mol. Cell. Biol.
14:
6683-6688
33.
Frost, J. A.,
T. D. Geppert,
M. H. Cobb, and
J. R. Feramisco.
1994.
A requirement for extracellular signal-regulated kinase (ERK) function in the
activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum.
Proc. Natl. Acad. Sci. USA
91:
3844-3848
34.
Frost, J. A.,
A. S. Alberts,
E. Sontag,
K. Guan,
M. C. Mumbay, and
J. R. Feramisco.
1994.
Simian virus 40 small t antigen cooperates with mitogen-activated kinases to stimulate AP-1 activity.
Mol. Cell. Biol.
14:
6244-6252
35.
DeSilva, D. R.,
W. S. Feeser,
E. J. Tancula, and
P. A. Scherle.
1996.
Anergic
T cells are defective in both Jun NH2-terminal kinase and mitogen-activated protein kinase signaling pathways.
J. Exp. Med.
183:
2017-2023
36. Akira, S., and T. Kishimoto. 1992. IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol. Rev. 127: 25-50 [Medline].
37.
Huang, J. H., and
W. S. L. Liao.
1994.
Induction of the mouse serum amyloid A3 gene by cytokines requires both C/EBP family proteins and a
novel constitutive nuclear factor.
Mol. Cell. Biol.
14:
4475-4484
38.
Ray, A., and
R. B. Ray.
1994.
Serum amyloid A gene expression under
acute-phase conditions involves participation of inducible C/EBP and
C/EBP
and their activation by phosphorylation.
Mol. Cell. Biol.
14:
4324-4332
39.
Alam, T.,
R. An, and
J. Papaconstantinou.
1992.
Differential expression of
three C/EBP isoforms in multiple tissues during the acute phase response.
J. Biol. Chem.
267:
5021-5024
40. Pope, R. M., A. Leutz, and S. A. Ness. 1994. C/EBP beta regulation of the tumor necrosis factor alpha gene. J. Clin. Invest. 94: 1449-1455 .
41.
Nakajima, T.,
S. Kinoshita,
T. Sasagawa,
K. Sasaki,
M. Naruto,
T. Kishimoto, and
S. Akira.
1993.
Phosphorylation at threonine-235 by a ras-dependent
mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6.
Proc. Natl. Acad. Sci. USA
90:
2207-2211
42.
Alvarez, E.,
I. C. Northwood,
F. A. Bonsalez,
D. A. Latour,
A. Seth,
C. Abate,
T. Curran, and
R. J. Davis.
1991.
Pro-Leu-Ser/Thr-Pro is a consensus primary sequence for substrate protein phosphorylation: characterization of the phosphorylation of c-myc and c-jun proteins by an epidermal
growth factor receptor threonine 669 protein kinase.
J. Biol. Chem.
266:
15277-15285
43.
Gupta, S.,
A. Seth, and
R. J. Davis.
1993.
Transactivation of gene expression
by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and
Ser-62.
Proc. Natl. Acad. Sci. USA
90:
3216-3220
44. Gille, H., S. D. Sharrocks, and P. E. Shaw. 1992. Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature 358: 414-417 [Medline].
45.
Abdel-Hafiz, H. A.,
L. E. Heasley,
J. M. Kyriakis,
J. Avruch,
D. J. Kroll,
G. L. Johnson, and
J. P. Hoeffler.
1992.
Activating transcription factor-2
DNA-binding activity is stimulated by phosphorylation catalyzed by p42
and p54 microtubule-associated protein kinases.
Mol. Endocrinol.
6:
2079-2089
46. Deng, T., and M. Karin. 1994. C-fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK. Nature 371: 171-175 [Medline].
47. Minden, A., A. Lin, F. Claret, A. Abo, and M. Karin. 1995. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc-42Hs. Cell 81: 1147-1157 [Medline].
48. Derijard, B., M. Hibi, I.-H. Wu, T. Barrett, B. Su, T. Deng, M. Karin, and R. J. Davis. 1994. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76: 1025-1037 [Medline].
This article has been cited by other articles:
 |
|
 |
|
  A. Lundberg, L. A. Wikberg, J. Ilonen, O. Vaarala, and M. F. Bottcher Lipopolysaccharide-Induced Immune Responses in Relation to the TLR4(Asp299Gly) Gene Polymorphism Clin. Vaccine Immunol., December 1, 2008; 15(12): 1878 - 1883. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Wijagkanalan, Y. Higuchi, S. Kawakami, M. Teshima, H. Sasaki, and M. Hashida Enhanced Anti-Inflammation of Inhaled Dexamethasone Palmitate Using Mannosylated Liposomes in an Endotoxin-Induced Lung Inflammation Model Mol. Pharmacol., November 1, 2008; 74(5): 1183 - 1192. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yan, G. Dalmasso, H. T. T. Nguyen, T. S. Obertone, L. Charrier-Hisamuddin, S. V. Sitaraman, and D. Merlin Nuclear Factor-{kappa}B Is a Critical Mediator of Ste20-Like Proline-/Alanine-Rich Kinase Regulation in Intestinal Inflammation Am. J. Pathol., October 1, 2008; 173(4): 1013 - 1028. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Tephly and A. B. Carter Asbestos-Induced MKP-3 Expression Augments TNF-{alpha} Gene Expression in Human Monocytes Am. J. Respir. Cell Mol. Biol., July 1, 2008; 39(1): 113 - 123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Garrett, K. Dietzmann-Maurer, L. Song, and K. E. Sullivan Polarization of Primary Human Monocytes by IFN-{gamma} Induces Chromatin Changes and Recruits RNA Pol II to the TNF-{alpha} Promoter J. Immunol., April 15, 2008; 180(8): 5257 - 5266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cabanski, M. Steinmuller, L. M. Marsh, E. Surdziel, W. Seeger, and J. Lohmeyer PKR Regulates TLR2/TLR4-Dependent Signaling in Murine Alveolar Macrophages Am. J. Respir. Cell Mol. Biol., January 1, 2008; 38(1): 26 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Tudhope, T. K. Finney-Hayward, A. G. Nicholson, R. J. Mayer, M. S. Barnette, P. J. Barnes, and L. E. Donnelly Different Mitogen-Activated Protein Kinase-Dependent Cytokine Responses in Cells of the Monocyte Lineage J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 306 - 312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Tephly and A. B. Carter Constitutive NADPH oxidase and increased mitochondrial respiratory chain activity regulate chemokine gene expression Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1143 - L1155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ikeda, A. Murakami, Y. Fujimura, H. Tachibana, K. Yamada, D. Masuda, K.-i. Hirano, S. Yamashita, and H. Ohigashi Aggregated Ursolic Acid, a Natural Triterpenoid, Induces IL-1beta Release from Murine Peritoneal Macrophages: Role of CD36 J. Immunol., April 15, 2007; 178(8): 4854 - 4864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Thorley, P. A. Ford, M. A. Giembycz, P. Goldstraw, A. Young, and T. D. Tetley Differential Regulation of Cytokine Release and Leukocyte Migration by Lipopolysaccharide-Stimulated Primary Human Lung Alveolar Type II Epithelial Cells and Macrophages J. Immunol., January 1, 2007; 178(1): 463 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Dubourdeau, R. Athman, V. Balloy, M. Huerre, M. Chignard, D. J. Philpott, J.-P. Latge, and O. Ibrahim-Granet Aspergillus fumigatus Induces Innate Immune Responses in Alveolar Macrophages through the MAPK Pathway Independently of TLR2 and TLR4 J. Immunol., September 15, 2006; 177(6): 3994 - 4001. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Birrell, S. Wong, K. McCluskie, M. C. Catley, E. L. Hardaker, S. Haj-Yahia, and M. G. Belvisi Second-Generation Inhibitors Demonstrate the Involvement of p38 Mitogen-Activated Protein Kinase in Post-Transcriptional Modulation of Inflammatory Mediator Production in Human and Rodent Airways J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1318 - 1327. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lendemans, M. Rani, C. Selbach, E. Kreuzfelder, F. U. Schade, and S. Flohe GM-CSF priming of human monocytes is dependent on ERK1/2 activation Innate Immunity, February 1, 2006; 12(1): 10 - 20. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Lee, B. Tomkowicz, B. D. Freedman, and R. G. Collman HIV-1 gp120-induced TNF-{alpha} production by primary human macrophages is mediated by phosphatidylinositol-3 (PI-3) kinase and mitogen-activated protein (MAP) kinase pathways J. Leukoc. Biol., October 1, 2005; 78(4): 1016 - 1023. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Chan, L. Li, C. E. McCall, and B. K. Yoza Endotoxin Tolerance Disrupts Chromatin Remodeling and NF-{kappa}B Transactivation at the IL-1{beta} Promoter J. Immunol., July 1, 2005; 175(1): 461 - 468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Strassheim, J.-Y. Kim, J.-S. Park, S. Mitra, and E. Abraham Involvement of SHIP in TLR2-Induced Neutrophil Activation and Acute Lung Injury J. Immunol., June 15, 2005; 174(12): 8064 - 8071. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Roos-Engstrand, A. Wallin, A. Bucht, J. Pourazar, T. Sandstrom, and A. Blomberg Increased expression of p38 MAPK in human bronchial epithelium after lipopolysaccharide exposure Eur. Respir. J., May 1, 2005; 25(5): 797 - 803. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Zhao, E. G. Shepherd, M. E. Manson, L. D. Nelin, A. Sorokin, and Y. Liu The Role of Mitogen-activated Protein Kinase Phosphatase-1 in the Response of Alveolar Macrophages to Lipopolysaccharide: ATTENUATION OF PROINFLAMMATORY CYTOKINE BIOSYNTHESIS VIA FEEDBACK CONTROL OF p38 J. Biol. Chem., March 4, 2005; 280(9): 8101 - 8108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Granata, A. Petraroli, E. Boilard, S. Bezzine, J. Bollinger, L. Del Vecchio, M. H. Gelb, G. Lambeau, G. Marone, and M. Triggiani Activation of Cytokine Production by Secreted Phospholipase A2 in Human Lung Macrophages Expressing the M-Type Receptor J. Immunol., January 1, 2005; 174(1): 464 - 474. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Baker, V. M. Brautigam, and J. J. Watters Estrogen Modulates Microglial Inflammatory Mediator Production via Interactions with Estrogen Receptor {beta} Endocrinology, November 1, 2004; 145(11): 5021 - 5032. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Jarrar, G. Y. Song, J. F. Kuebler, L. W. Rue, K. I. Bland, and I. H. Chaudry The Effect of Inhibition of a Major Cell Signaling Pathway Following Trauma Hemorrhage on Hepatic Injury and Interleukin 6 Levels Arch Surg, August 1, 2004; 139(8): 896 - 901. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Carter, L. A. Tephly, S. Venkataraman, L. W. Oberley, Y. Zhang, G. R. Buettner, D. R. Spitz, and G. W. Hunninghake High Levels of Catalase and Glutathione Peroxidase Activity Dampen H2O2 Signaling in Human Alveolar Macrophages Am. J. Respir. Cell Mol. Biol., July 1, 2004; 31(1): 43 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Strassheim, K. Asehnoune, J.-S. Park, J.-Y. Kim, Q. He, D. Richter, K. Kuhn, S. Mitra, and E. Abraham Phosphoinositide 3-Kinase and Akt Occupy Central Roles in Inflammatory Responses of Toll-Like Receptor 2-Stimulated Neutrophils J. Immunol., May 1, 2004; 172(9): 5727 - 5733. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Mercer, N. Kolesnikova, J. Sonett, and J. D'Armiento Extracellular Regulated Kinase/Mitogen Activated Protein Kinase Is Up-regulated in Pulmonary Emphysema and Mediates Matrix Metalloproteinase-1 Induction by Cigarette Smoke J. Biol. Chem., April 23, 2004; 279(17): 17690 - 17696. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Aga, J. J. Watters, Z. A. Pfeiffer, G. J. Wiepz, J. A. Sommer, and P. J. Bertics Evidence for nucleotide receptor modulation of cross talk between MAP kinase and NF-{kappa}B signaling pathways in murine RAW 264.7 macrophages Am J Physiol Cell Physiol, April 1, 2004; 286(4): C923 - C930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Raychaudhuri, S. Abraham, T. L. Bonfield, A. Malur, A. Deb, J. A. DiDonato, M. S. Kavuru, and M. J. Thomassen Surfactant Blocks Lipopolysaccharide Signaling by Inhibiting both Mitogen-Activated Protein and I{kappa}B Kinases in Human Alveolar Macrophages Am. J. Respir. Cell Mol. Biol., February 1, 2004; 30(2): 228 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P J Barnes Chronic obstructive pulmonary disease * 12: New treatments for COPD Thorax, September 1, 2003; 58(9): 803 - 808. [Full Text] [PDF]
|
|
|
|
|
|
M. M. Monick, L. S. Powers, N. S. Butler, and G. W. Hunninghake Inhibition of Rho Family GTPases Results in Increased TNF-{alpha} Production After Lipopolysaccharide Exposure J. Immunol., September 1, 2003; 171(5): 2625 - 2630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sengul, C. Zwizinski, and V. Batuman Role of MAPK pathways in light chain-induced cytokine production in human proximal tubule cells Am J Physiol Renal Physiol, June 1, 2003; 284(6): F1245 - F1254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Ingram, A. B. Rice, J. Santos, B. Van Houten, and J. C. Bonner Vanadium-induced HB-EGF expression in human lung fibroblasts is oxidant dependent and requires MAP kinases Am J Physiol Lung Cell Mol Physiol, May 1, 2003; 284(5): L774 - L782. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Rice, J. L. Ingram, and J. C. Bonner p38 Mitogen-Activated Protein Kinase Regulates Growth Factor-Induced Mitogenesis of Rat Pulmonary Myofibroblasts Am. J. Respir. Cell Mol. Biol., December 1, 2002; 27(6): 759 - 765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Bshesh, B. Zhao, D. Spight, I. Biaggioni, I. Feokistov, A. Denenberg, H. R. Wong, and T. P. Shanley The A2A receptor mediates an endogenous regulatory pathway of cytokine expression in THP-1 cells J. Leukoc. Biol., November 1, 2002; 72(5): 1027 - 1036. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Nick, S. K. Young, P. G. Arndt, J. G. Lieber, B. T. Suratt, K. R. Poch, N. J. Avdi, K. C. Malcolm, C. Taube, P. M. Henson, et al. Selective Suppression of Neutrophil Accumulation in Ongoing Pulmonary Inflammation by Systemic Inhibition of p38 Mitogen-Activated Protein Kinase J. Immunol., November 1, 2002; 169(9): 5260 - 5269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Jarrar, J. F. Kuebler, L. W. Rue III, S. Matalon, P. Wang, K. I. Bland, and I. H. Chaudry Alveolar macrophage activation after trauma-hemorrhage and sepsis is dependent on NF-kappa B and MAPK/ERK mechanisms Am J Physiol Lung Cell Mol Physiol, October 1, 2002; 283(4): L799 - L805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Monick, P. K. Robeff, N. S. Butler, D. M. Flaherty, A. B. Carter, M. W. Peterson, and G. W. Hunninghake Phosphatidylinositol 3-Kinase Activity Negatively Regulates Stability of Cyclooxygenase 2 mRNA J. Biol. Chem., August 30, 2002; 277(36): 32992 - 33000. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Monick, L. Powers, N. Butler, T. Yarovinsky, and G. W. Hunninghake Interaction of matrix with integrin receptors is required for optimal LPS-induced MAP kinase activation Am J Physiol Lung Cell Mol Physiol, August 1, 2002; 283(2): L390 - L402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.M. Monick and G.W. Hunninghake Activation of second messenger pathways in alveolar macrophages by endotoxin Eur. Respir. J., July 1, 2002; 20(1): 210 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-Y. Hsu and M.-H. Wen Lipopolysaccharide-mediated Reactive Oxygen Species and Signal Transduction in the Regulation of Interleukin-1 Gene Expression J. Biol. Chem., June 14, 2002; 277(25): 22131 - 22139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Miller, K. Welty-Wolf, M. S. Carraway, M. Ezban, A. Ghio, H. Suliman, and C. A. Piantadosi Extrinsic Coagulation Blockade Attenuates Lung Injury and Proinflammatory Cytokine Release after Intratracheal Lipopolysaccharide Am. J. Respir. Cell Mol. Biol., June 1, 2002; 26(6): 650 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Graness, C. E. Chwieralski, D. Reinhold, L. Thim, and W. Hoffmann Protein Kinase C and ERK Activation Are Required for TFF- peptide-stimulated Bronchial Epithelial Cell Migration and Tumor Necrosis Factor-alpha -induced Interleukin-6 (IL-6) and IL-8 Secretion J. Biol. Chem., May 17, 2002; 277(21): 18440 - 18446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Weber, J.-M. Chen, and S. M. Levitz Inhibition of Mitogen-Activated Protein Kinase Signaling by Chloroquine J. Immunol., May 15, 2002; 168(10): 5303 - 5309. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Watters, J. A. Sommer, Z. A. Pfeiffer, U. Prabhu, A. N. Guerra, and P. J. Bertics A Differential Role for the Mitogen-activated Protein Kinases in Lipopolysaccharide Signaling. THE MEK/ERK PATHWAY IS NOT ESSENTIAL FOR NITRIC OXIDE AND INTERLEUKIN 1beta PRODUCTION J. Biol. Chem., March 8, 2002; 277(11): 9077 - 9087. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ouadrhiri, C. Pilette, R. C. Monteiro, J.-P. Vaerman, and Y. Sibille Effect of IgA on Respiratory Burst and Cytokine Release by Human Alveolar Macrophages . Role of ERK1/2 Mitogen-Activated Protein Kinases and NF-kappa B Am. J. Respir. Cell Mol. Biol., March 1, 2002; 26(3): 315 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Pfeilschifter, R. Koditz, M. Pfohl, and H. Schatz Changes in Proinflammatory Cytokine Activity after Menopause Endocr. Rev., February 1, 2002; 23(1): 90 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Panenka, H. Jijon, L. M. Herx, J. N. Armstrong, D. Feighan, T. Wei, V. W. Yong, R. M. Ransohoff, and B. A. MacVicar P2X7-Like Receptor Activation in Astrocytes Increases Chemokine Monocyte Chemoattractant Protein-1 Expression via Mitogen-Activated Protein Kinase J. Neurosci., September 15, 2001; 21(18): 7135 - 7142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Reiling, A. Blumenthal, H.-D. Flad, M. Ernst, and S. Ehlers Mycobacteria-Induced TNF-{alpha} and IL-10 Formation by Human Macrophages Is Differentially Regulated at the Level of Mitogen-Activated Protein Kinase Activity J. Immunol., September 15, 2001; 167(6): 3339 - 3345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. HALLSWORTH, L. M. MOIR, D. LAI, and S. J. HIRST Inhibitors of Mitogen-activated Protein Kinases Differentially Regulate Eosinophil-activating Cytokine Release from Human Airway Smooth Muscle Am. J. Respir. Crit. Care Med., August 15, 2001; 164(4): 688 - 697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.J. Barnes Cytokine modulators as novel therapies for airway disease Eur. Respir. J., July 2, 2001; 18(34_suppl): 67S - 77s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Dreskin, G. W. Thomas, S. N. Dale, and L. E. Heasley Isoforms of Jun Kinase Are Differentially Expressed and Activated in Human Monocyte/Macrophage (THP-1) Cells J. Immunol., May 1, 2001; 166(9): 5646 - 5653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Shoham, C. Huang, J.-M. Chen, D. T. Golenbock, and S. M. Levitz Toll-Like Receptor 4 Mediates Intracellular Signaling Without TNF-{{alpha}} Release in Response to Cryptococcus neoformans Polysaccharide Capsule J. Immunol., April 1, 2001; 166(7): 4620 - 4626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Monick, A. B. Carter, P. K. Robeff, D. M. Flaherty, M. W. Peterson, and G. W. Hunninghake Lipopolysaccharide Activates Akt in Human Alveolar Macrophages Resulting in Nuclear Accumulation and Transcriptional Activity of {{beta}}-Catenin J. Immunol., April 1, 2001; 166(7): 4713 - 4720. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Chakravortty, Y. Kato, T. Sugiyama, N. Koide, M. M. Mu, T. Yoshida, and T. Yokochi Inhibition of Caspase 3 Abrogates Lipopolysaccharide-Induced Nitric Oxide Production by Preventing Activation of NF-{kappa}B and c-Jun NH2-Terminal Kinase/Stress-Activated Protein Kinase in RAW 264.7 Murine Macrophage Cells Infect. Immun., March 1, 2001; 69(3): 1315 - 1321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Chakravortty, Y. Kato, T. Sugiyama, N. Koide, M. M. Mu, T. Yoshida, and T. Yokochi The Inhibitory Action of Sodium Arsenite on Lipopolysaccharide-Induced Nitric Oxide Production in RAW 267.4 Macrophage Cells: A Role of Raf-1 in Lipopolysaccharide Signaling J. Immunol., February 1, 2001; 166(3): 2011 - 2017. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Schmidt, E. Caron, and A. Hall Lipopolysaccharide-Induced Activation of {beta}2-Integrin Function in Macrophages Requires Irak Kinase Activity, p38 Mitogen- Activated Protein Kinase, and the Rap1 GTPase Mol. Cell. Biol., January 15, 2001; 21(2): 438 - 448. [Abstract] [Full Text]
|
|
|
|
|
|
K. M. Krishna Rao MAP kinase activation in macrophages J. Leukoc. Biol., January 1, 2001; 69(1): 3 - 10. [Abstract] [Full Text]
|
|
|
|
|
|
T. A. Blinman, I. Gukovsky, M. Mouria, V. Zaninovic, E. Livingston, S. J. Pandol, and A. S. Gukovskaya Activation of pancreatic acinar cells on isolation from tissue: cytokine upregulation via p38 MAP kinase Am J Physiol Cell Physiol, December 1, 2000; 279(6): C1993 - C2003. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Monick, A. B. Carter, D. M. Flaherty, M. W. Peterson, and G. W. Hunninghake Protein Kinase C {zeta} Plays a Central Role in Activation of the p42/44 Mitogen-Activated Protein Kinase by Endotoxin in Alveolar Macrophages J. Immunol., October 15, 2000; 165(8): 4632 - 4639. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hou, S. Moller, L. Edvinsson, and D. Erlinge Cytokines Induce Upregulation of Vascular P2Y2 Receptors and Increased Mitogenic Responses to UTP and ATP Arterioscler Thromb Vasc Biol, September 1, 2000; 20(9): 2064 - 2069. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Lakics, A. E. Medvedev, S. Okada, and S. N. Vogel Inhibition of LPS-induced Cytokines by Bcl-xL in a Murine Macrophage Cell Line J. Immunol., September 1, 2000; 165(5): 2729 - 2737. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Weber and S. M. Levitz Chloroquine Interferes with Lipopolysaccharide-Induced TNF-{alpha} Gene Expression by a Nonlysosomotropic Mechanism J. Immunol., August 1, 2000; 165(3): 1534 - 1540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Hedges, C. A. Singer, and W. T. Gerthoffer Mitogen-Activated Protein Kinases Regulate Cytokine Gene Expression in Human Airway Myocytes Am. J. Respir. Cell Mol. Biol., July 1, 2000; 23(1): 86 - 94. [Abstract] [Full Text]
|
|
|
|
|
|
R. F. Robledo, S. A. Buder-Hoffmann, A. B. Cummins, E. S. Walsh, D. J. Taatjes, and B. T. Mossman Increased Phosphorylated Extracellular Signal-Regulated Kinase Immunoreactivity Associated with Proliferative and Morphologic Lung Alterations after Chrysotile Asbestos Inhalation in Mice Am. J. Pathol., April 1, 2000; 156(4): 1307 - 1316. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Matsuguchi, K. Takagi, T. Musikacharoen, and Y. Yoshikai Gene expressions of lipopolysaccharide receptors, toll-like receptors 2 and 4, are differently regulated in mouse T lymphocytes Blood, February 15, 2000; 95(4): 1378 - 1385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Boland, V. Bonvallot, T. Fournier, A. Baeza-Squiban, M. Aubier, and F. Marano Mechanisms of GM-CSF increase by diesel exhaust particles in human airway epithelial cells Am J Physiol Lung Cell Mol Physiol, January 1, 2000; 278(1): L25 - L32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Carter, K. L. Knudtson, M. M. Monick, and G. W. Hunninghake The p38 Mitogen-activated Protein Kinase Is Required for NF-kappa B-dependent Gene Expression. THE ROLE OF TATA-BINDING PROTEIN (TBP) J. Biol. Chem., October 22, 1999; 274(43): 30858 - 30863. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Lucas and J. T. Flynn Signal transduction pathways involved in lipopolysaccharide-induced production of PGE2 by human microvascular endothelial cells Innate Immunity, October 1, 1999; 5(5-6): 307 - 317. [Abstract] [PDF]
|
|
|
|
|
|
A. B. Carter and G. W. Hunninghake A Constitutive Active MEK right-arrow ERK Pathway Negatively Regulates NF-kappa B-dependent Gene Expression by Modulating TATA-binding Protein Phosphorylation J. Biol. Chem., September 1, 2000; 275(36): 27858 - 27864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Carter, L. A. Tephly, and G. W. Hunninghake The Absence of Activator Protein 1-dependent Gene Expression in THP-1 Macrophages Stimulated with Phorbol Esters Is Due to Lack of p38 Mitogen-activated Protein Kinase Activation J. Biol. Chem., August 31, 2001; 276(36): 33826 - 33832. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |